Abstract
PD-1 and its ligand PD-L1 belong to the co-inhibition molecules, which can downregulate immune responses. The PD-L1 polymorphism and the level of soluble PD-L1 (sPD-L1) were investigated in non-small cell lung cancer (NSCLC). A total of 288 NSCLC patients and 300 controls were enrolled. An A/C polymorphism at position 8923 in the PD-L1 gene was genotyped using the polymerase chain reaction-restriction fragment length polymorphism method. The prevalence of the 8923C allele was significantly higher in NSCLC patients than controls (10.2% versus 5.3%, p = 0.002, odds ratio 2.03, 95% confidence interval 1.30-3.17; data were adjusted for age and sex). NSCLC patients also showed increased plasma levels of sPD-L1 compared to controls (1.92 ng/mL versus 0.91 ng/mL, p<0.001). Furthermore, lung adenocarcinoma patients had higher sPD-L1 levels than patients with squamous cell carcinoma (p<0.01). However, no association was observed between the different genetic variants and plasma concentrations of sPD-L1. The PD-L1 8923A/C polymorphism could be associated with increased susceptibility to NSCLC. Plasma levels of sPD-L1 are significantly increased in NSCLC patients, especially those with adenocarcinoma.
References
Dec 2, 1999·Nature Medicine·H DongL Chen
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M K Oaks, K M Hallett
Oct 6, 2000·Immunity·P JeanninY Delneste
Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
Mar 20, 2004·Experimental & Molecular Medicine·Hyo Won JungByoung Se Kwon
Dec 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bing WanJingwu Z Zhang
Mar 30, 2007·Journal of Internal Medicine·P SakthivelA K Lefvert
Jul 17, 2007·Immunity·Manish J ButteGordon J Freeman
Mar 7, 2008·European Journal of Endocrinology·Mina HayashiIchiro Komiya
Jul 1, 2008·Molecular Immunology·Manish J ButteArlene H Sharpe
Sep 3, 2009·Biochemical and Biophysical Research Communications·Yosuke KamimuraMiyuki Azuma
Oct 24, 2009·The Journal of Clinical Endocrinology and Metabolism·Anna L MitchellSimon H S Pearce
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xavier FrigolaEugene D Kwon
Nov 22, 2012·Asia-Pacific Journal of Clinical Oncology·Yan-bin ChenJian-An Huang
Feb 13, 2013·Metabolism: Clinical and Experimental·Bimin ShiXueguang Zhang
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mario Sznol, Lieping Chen
Mar 21, 2013·British Journal of Cancer·S A Quezada, K S Peggs
Nov 13, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Vamsidhar VelchetiDavid L Rimm
Feb 6, 2014·Blood·David D W TwaChristian Steidl
May 13, 2014·Diabetes/metabolism Research and Reviews·Carolina PizarroFrancisco Pérez-Bravo
Oct 29, 2014·British Journal of Cancer·A D'InceccoF Cappuzzo
Citations
Dec 24, 2018·American Journal of Reproductive Immunology : AJRI·Li-Ling WangAi-Hua Liao
Jul 6, 2016·British Journal of Cancer·Vishwajith SridharanJonathan D Schoenfeld
Jun 4, 2016·Journal of Cancer Research and Clinical Oncology·Naoki TakahashiYasuhide Yamada
Mar 6, 2018·Medicine·Wei WeiChangping Wu
Oct 3, 2019·Medicine·Jia YangJinming Yu
Dec 13, 2017·Oncotarget·Xinxin Zhu, Jinghe Lang
Mar 14, 2020·Journal of Immunotherapy·Jiabei HeYu Tang
Dec 20, 2018·Cancer Immunology, Immunotherapy : CII·Nadia B HassounahEsra A Akbay
May 31, 2020·Cancers·Angelo CastelloEgesta Lopci
Oct 27, 2017·Expert Review of Molecular Diagnostics·Paul Hofman
Jan 23, 2020·Nature Reviews. Immunology·Dhouha DaassiGordon J Freeman
Jun 19, 2018·Frontiers in Pharmacology·Yiting WangJie Xu
Aug 14, 2019·Cancers·Mohammad HashemiEmilia Wiechec
May 28, 2019·Frontiers in Genetics·Florence de FraipontBeatrice Eymin
Sep 29, 2020·Frontiers in Oncology·Yijun JiaCaicun Zhou
Dec 3, 2016·PloS One·Kentaro MinagawaAntonio Di Stasi
Oct 25, 2017·Cancer Biomarkers : Section a of Disease Markers·Rong-Miao ZhouBao-En Shan
Oct 28, 2020·Thoracic Cancer·Shuji MurakamiYuichiro Ohe
Nov 2, 2019·Critical Reviews in Oncology/hematology·Taher Abu HejlehGerald Clamon
Feb 2, 2021·Frontiers in Immunology·Marta WagnerLidia Karabon
Feb 2, 2021·BioMed Research International·Rui HanJianbing Ding
Mar 8, 2021·Bioelectrochemistry·Yu XingXinxia Cai
Mar 16, 2021·European Journal of Haematology·Julie B MortensenFrancesco d'Amore
Apr 14, 2018·International Immunopharmacology·Xiaofeng HuangHua Wang
Sep 22, 2018·Immunology Letters·A León-FloresG Reyes-Terán
Jun 27, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Honggang YingXueli Bai